Infectious Diseases
Drug company responds to disease epidemic caused by Clostridium difficile
Published in TB and Outbreaks Week, November 1st, 2005
These efforts include the launch of a major educational campaign to raise clinician awareness of the changing landscape of C. difficile-associated disease. ViroPharma commercializes Vancocin, which is indicated for the treatment of antibiotic-associated pseudomembranous colitis caused by C. difficile.
New information on an emerging strain of C. difficile was published in the September 24 edition of the Lancet (2005;366:1079-84). The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Drug Resistance
Single MRSA clone spreading transregionally between drug users in Switzerland - Epidemiology
Widespread B. cenocepacia clone identified in CF patients in Czech Republic - Laboratory Biosafety
Biosafety level 3 facilities safeguard from SARS-CoV-infected autopsy specimens - Malaria
Puddles created by the 2004 tsunami facilitate increased breeding of malaria vector - Shigellosis Outbreak
Researchers report shigellosis outbreak in swimmers in freshwater lake - Argentine Hemorrhagic Fever
Researchers recommend use of Candid 1 vaccine in children under 15 years old - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
